Reply

We thank Belovay et  al for their comments on our paper regarding how iridotomy location affects the likelihood of post-laser peripheral iridotomy (LPI) symptoms.1 We also congratulate them on their prior randomized trial on the same topic,2 and welcome an open discussion regarding why their trial noted significantly more new post-LPI linear dysphotopsias with superiorly placed iridotomies as compared with nasal/temporal LPIs (P = 0.002), whereas our trial showed no such difference (P = 0.6). Neither study showed group differences with regard to overall rates of dysphotopsia or other types of dysphotopsia.

Source: Ophthalmology - April 19, 2018 Category: Opthalmology Authors: Kavitha Srinivasan, Nazlee Zebardast, Rengaraj Venkatesh, Pradeep Y. Ramulu Tags: Correspondence Source Type: research